Study demonstrates safety of microbiota transplant therapy in stem cell transplant and leukemia patients

Published in the Journal of Clinical Oncology, University of Minnesota Medical School researchers led a study that demonstrated the safety of using microbiota transplant therapy (MTT) in patients with acute myeloid leukemia (AML)—a type of blood cancer—and recipients of hematopoietic cell transplantation (HCT).

Leave A Comment

Your email address will not be published. Required fields are marked *